Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17058228 | 0.86 | NR1H2 (0.50) | ALDH1A1CA2MEN1NPC1RAB9A | |
| SCHEMBL3880071 | 0.84 | — | — | |
| SCHEMBL15300614 | 0.76 | ALDH1A1 (0.39) | ALDH1A1MAPK1MAOA | |
| SCHEMBL890841 | 0.76 | — | — | |
| SCHEMBL22606565 | 0.67 | ALDH1A1 (0.42) | ALDH1A1MAPK1MAOACA2SLC6A4 | |
| SCHEMBL13990697 | 0.66 | ALDH1A1 (0.40) | ALDH1A1MAPK1MAOACA2SLC6A4 | |
| SCHEMBL890801 | 0.66 | — | — | |
| SCHEMBL890762 | 0.65 | — | — | |
| SCHEMBL890862 | 0.64 | — | — | |
| SCHEMBL22755713 | 0.64 | NPC1 (0.52) | ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118745246-A | High refractive material based on biomass magnolol and honokiol | 中国科学院上海有机化学研究所 | 2024-10-08 | — | — | CN | claimed |
| US-6391433-B1 | — | — | None | — | — | US | disclosed |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-4582463-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | Kureha Corporation (JP) | 2025-07-09 | — | — | EP | disclosed |
| EP-4582459-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | Kureha Corporation (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-119768447-A | Curable composition, cured product, and method for producing cured product | 株式会社吴羽 | 2025-04-04 | — | — | CN | disclosed |
| CN-119768439-A | Rubber-bonded cellulose fiber, method for producing same, resin composition, method for producing same, and cured resin composition | 株式会社吴羽 | 2025-04-04 | — | — | CN | disclosed |
| CN-118745246-A | High refractive material based on biomass magnolol and honokiol | 中国科学院上海有机化学研究所 | 2024-10-08 | — | — | CN | disclosed |
| CN-118667123-A | Xylylene diisocyanate composition, resin, and polymerizable composition | 三井化学株式会社 | 2024-09-20 | — | — | CN | disclosed |
| EP-0506315-A2 | Optical urethane resins and plastic lenses comprising the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-09-30 | — | — | EP | disclosed |
| US-5126388-A | Sulfur-containing polyurethane or polythiourethane and internal mold release agent | MITSUI TOATSU CHEMICALS, INC. (JP) | 1992-06-30 | — | — | US | disclosed |
| US-5084545-A | Polythiourethanes for impact strength, lightweight lenses | MITSUI TOATSU CHEMICALS, INC. (JP) | 1992-01-28 | — | — | US | disclosed |
| US-5059673-A | bis(isocyanatomethyl)-norbornane or -4,7methonohexahydroindan e high refractive index, lightweight, high impact | MITSUI TOATSU CHEMICALS, INC. (JP) | 1991-10-22 | — | — | US | disclosed |
| US-5021503-A | Polythiourethanes from sulfur-containing aliphatic diisocyanates and polythiols or polyols; colorless | MITSUI TOATSU CHEMICALS, INC. (JP) | 1991-06-04 | — | — | US | disclosed |
| US-5013496-A | Polyurethane or polythiourethane | MITSUI TOATSU CHEMICALS, INC. (JP) | 1991-05-07 | — | — | US | disclosed |
| EP-0422836-A2 | Resin for urethane lenses, lenses comprising the resin, and a process for preparation of the resin and the lenses | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1991-04-17 | — | — | EP | disclosed |
| EP-0374258-A1 | HIGH REFRACTIVE INDEX LENS AND METHOD FOR ITS PRODUCTION | MITSUI CHEMICALS, INC. (JP) | 1990-06-27 | — | — | EP | disclosed |
| EP-0330363-A2 | Highly-refractive plastic lens and process for making the lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329387-A2 | Plastic lens, and method for its preparation | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | CROCC, WASF2, DCXR | ALDH1A1 1879/4885MAPK1 2443/4885MAOA 4767/4885 |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | EHMT1, EHMT2, ASH2L | ALDH1A1 265/4885MAPK1 2597/4885MAOA 1356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.